The importance of mutation order has been demonstrated in MPN by Ortmann et al.13, who show that two subpopulations of patients with MPN can be distinguished by the order of mutation acquisition between the TET2 and JAK2 genes, and that these subpopulations have distinct clinical characteristics. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.